Breaking News Instant updates and real-time market news.

CRM

Salesforce

$154.68

1.705 (1.11%)

16:10
08/29/18
08/29
16:10
08/29/18
16:10

Salesforce raises FY19 operating cash flow growth view to 15%-16% from 14%-15%

  • 29

    Aug

  • 06

    Sep

  • 07

    Sep

  • 24

    Sep

  • 25

    Sep

CRM Salesforce
$154.68

1.705 (1.11%)

08/21/18
COWN
08/21/18
NO CHANGE
Target $165
COWN
Outperform
Salesforce price target raised to $165 from $155 at Cowen
Cowen analyst J. Derrick Wood raised his price target on Salesforce to $165 from $155 ahead of Q2 results. The analyst said channel checks indicate a solid beat and raise set-up, citing a re-acceleration in Sales and Service Cloud, growing Einstein adoption, and lower competition. Wood reiterated his Outperform rating on Salesforce shares.
08/22/18
JEFF
08/22/18
NO CHANGE
Target $168
JEFF
Buy
Salesforce price target raised to $168 from $155 at Jefferies
Jefferies analyst John DiFucci raised his price target for Salesforce to $168 ahead of the company's Q2 results. The analyst expects Salesforce meet or exceed consensus Q2 billings growth of 22%. Enterprise checks reflect strong results, particularly in Europe and across verticals, and a "healthy" second half of 2018 pipeline, DiFucci tells investors in a pre-earnings research note. The analyst keeps a Buy rating on the shares.
08/22/18
WEDB
08/22/18
NO CHANGE
Target $160
WEDB
Outperform
Salesforce price target raised to $160 from $150 at Wedbush
Wedbush analyst Steve Koenig raised his price target for Salesforce to $160 from $150 as his checks point to a strong demand environment and sustained momentum for Salesforce. While the analyst does not have evidence to suggest a repeat of the Q1 large deal performance, his checks anecdotally point to large deals closed in major verticals, and more in the pipeline. Koenig expects Salesforce's Q2 numbers will be strong, although the run-up in the shares year to date and over the last 90 days may create a more difficult setup. The analyst reiterates an Outperform rating on the shares.
08/22/18
RBCM
08/22/18
NO CHANGE
Target $155
RBCM
Outperform
Salesforce price target raised to $155 from $146 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Salesforce to $155 and kept his Outperform rating, saying his checks suggest continued "strong demand, success in multi-cloud deals at enterprise customers and pricing power". The analyst notes that the set-up on the stock is also "attractive" considering the implied organic constant-currency billings growth of around 15%. MacMillan adds that Salesforce has a historical pattern of beating Q2 consensus by about 5%, though this year's results may be skewed by the adoption of ASC606 standard.

TODAY'S FREE FLY STORIES

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

16:18
09/20/18
09/20
16:18
09/20/18
16:18
Hot Stocks
Pier 1 Imports CEO says disappointing Q2 reflects 'execution challenges' »

CEO Alasdair James said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CULP

Culp, Inc.

$24.75

-0.1 (-0.40%)

16:18
09/20/18
09/20
16:18
09/20/18
16:18
Hot Stocks
Culp CEO Saxon to assume additional role of vice chairman »

Culp announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ED

Consolidated Edison

$78.43

0.11 (0.14%)

16:17
09/20/18
09/20
16:17
09/20/18
16:17
Hot Stocks
Con Edison to acquire 981 MW of renewable electric production projects »

Consolidated Edison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

DOV

Dover

$89.36

0.94 (1.06%)

16:17
09/20/18
09/20
16:17
09/20/18
16:17
Hot Stocks
Pole/Zero awarded over $66M contract by U.S. Department of Defense »

Pole/Zero, part of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

16:17
09/20/18
09/20
16:17
09/20/18
16:17
Hot Stocks
Pier 1 Imports discontinues FY19 guidance »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/20/18
09/20
16:17
09/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INDB

Independent Bank

$89.85

0.65 (0.73%)

, BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Hot Stocks
Independent Bank, Blue Hills sign merger pact for Rockland to acquire BHB »

Independent Bank Corp.…

INDB

Independent Bank

$89.85

0.65 (0.73%)

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Earnings
Pier 1 Imports reports preliminary Q2 EPS (64c)-(62c), consensus (55c) »

Reports Q2 prelim SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOD

Gladstone

$19.01

0.28 (1.49%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Hot Stocks
Gladstone acquires $8.3M property in Delaware, Ohio »

Gladstone Commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
09/20/18
09/20
16:16
09/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.03

0.98 (2.18%)

16:15
09/20/18
09/20
16:15
09/20/18
16:15
Hot Stocks
Micron appoints Mike Bokan SVP Worldwide Sales »

Micron Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

16:15
09/20/18
09/20
16:15
09/20/18
16:15
General news
Breaking General news story  »

Week of 9/10 Money Supply…

16:15
09/20/18
09/20
16:15
09/20/18
16:15
General news
Breaking General news story  »

Week of 9/19 Fed Balance…

ADVM

Adverum Biotechnologies

$5.70

-0.15 (-2.56%)

16:14
09/20/18
09/20
16:14
09/20/18
16:14
Initiation
Adverum Biotechnologies initiated  »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

GBL

GAMCO Investors

$26.00

0.44 (1.72%)

, GCP

GCP Applied Technologies

$26.25

0.25 (0.96%)

16:14
09/20/18
09/20
16:14
09/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, GCP Applied Technologies »

Gabelli reports 5% stake…

GBL

GAMCO Investors

$26.00

0.44 (1.72%)

GCP

GCP Applied Technologies

$26.25

0.25 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSLT

Castlight Health

$2.90

0.1 (3.57%)

16:13
09/20/18
09/20
16:13
09/20/18
16:13
Hot Stocks
Breaking Hot Stocks news story on Castlight Health »

Neil Gagnon reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.87

0.575 (1.73%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
Breaking Hot Stocks news story on United Natural Foods »

United Natural Foods down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

UNFI

United Natural Foods

$33.79

0.5 (1.50%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
United Natural Foods says results reflect higher than anticipated freight costs »

"We continued to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Steelcase »

Steelcase up 9.9% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FATE

Fate Therapeutics

$13.99

0.64 (4.79%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Syndicate
Fate Therapeutics files to sell common stock, no amount given »

Jefferies, Piper Jaffray,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Earnings
Breaking Earnings news story on Steelcase »

Steelcase sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

T

AT&T

$33.38

0.02 (0.06%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
AT&T recommends that shareholders reject mini-tender from Ponos Industries »

AT&T has learned that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

BHBK

Blue Hills Bancorp

$23.50

0.35 (1.51%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$18.98

0.49 (2.65%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Karyopharm announces oral presentation relating to selinexor »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Earnings
Steelcase sees Q3 EPS 28c-33c, consensus 25c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.